FindTrial
Sign In

Study of comparative effect of Nagakesar Churna AND Pushyanug Churna for management of Sweta Pradara

COMPARATIVE EFFECT OF NAGAKESAR CHURNA AND PUSHYANUG CHURNA IN SHWETA PRADARA - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089854
Enrollment
60
Registered
2025-06-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N768- Other specified inflammation of vagina and vulva

Interventions

None listed

Sponsors

Monika Goswami
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with abovementioned signs and symptoms as under Diagnostic criteria 2. Patients diagnosed as a case of Shweta Pradara. 3. Patients diagnosed as a case or recurrence of Candida Albicans 4. Patients with Yonivyapda having symptoms like Yonistrava, Yonikandu and Yonidaurghandya.

Exclusion criteria

Exclusion criteria: 1. Positive VDRL, HIV, HBSAG(STDs) 2. Patients on Oral contraceptive Pills or IUCDs 3. Presence of infective organism except Candida albicans 4. Positive PAP smear ( premalignancy or malignancy of genital tract) 5. Presence of uncontrolled diabetes, immunosuppressant condition 6. Presence of any uterine tumor or growth, cervical polyp

Design outcomes

Primary

MeasureTime frame
No Vaginal Discharge &Vulvovaginal pruritisTimepoint: No Vaginal Discharge &Vulvovaginal pruritis - 15 days after drug therapy—

Secondary

MeasureTime frame
No Recurrence of symptomsTimepoint: No Recurrence of symptoms - confirmation 15 days after drug therapy—

Countries

India

Contacts

Public ContactMonika Goswami

Uttaranchal Ayurvedic College, Dehradun

drimranpatel@gmail.com9370106316

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026